Tag Archives: pneumococcal disease

Pfizer demonstrates safety of Prevnar 13 for older children

TweetPfizer Inc., announced the results of a phase three study on Monday demonstrating that Prevnar 13(R) showed immunogenicity and established a safety profile in children ages five through 17. Prevnar 13(R) – Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) – … Read More »

Filed in Vaccine Development | Tagged | Comments Off

Pfizer, Glaxo sign 10-year vaccine deal for poor

LONDON Read More »

Filed in News, Vaccine Development | Tagged , , | Comments Off

Drugmakers agree on vaccines deal for developing nations

LONDON Read More »

Filed in News, Vaccine Development | Tagged , | Comments Off

Young kids should get new Prevnar, U.S. experts say

Children younger than 5 who already got four doses of Pfizer Inc.’s Prevnar 13 vaccine should get a fifth booster dose of the new version that covers more strains of pneumonia-causing bacteria. Read More »

Filed in News, Vaccine Development | Tagged , | Comments Off

Infection persists, despite vaccine, analysis finds

A vaccine introduced in 2000 has been highly effective in reducing the number of severe lung, blood and brain infections in infants and children. But at the same time, a serious and sometimes fatal complication has become more common. Read More »

Filed in News, Vaccine Development | Tagged , | Comments Off

PATH paying FDA for work on a pneumococcal disease vaccine

A nonprofit organization is paying the Food and Drug Administration to help develop a better vaccine against pneumococcal disease in poor countries, The New York Times reported Feb. 1. Read More »

Filed in FDA, News | Tagged , | Comments Off

Partnership to support vaccine formulation across PATH projects

PATH, an international nonprofit global health organization, recently signed an agreement with the University of Kansas Center for Research to support the advancement of vaccine candidates across its vaccine development portfolio. Read More »

Filed in News, Vaccine Development | Tagged , | Comments Off

Pneumonia shots not going to all who need them, authorities say

While a nationwide push for vaccination against H1N1 and seasonal flu has led to long lines for shots, another vaccine against a common and deadly flu complication Read More »

Filed in CDC, News | Tagged , | Comments Off

FDA panel backs Pfizer’s enhanced vaccine for children